Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 55 | 2024 | 2399 | 9.200 |
Why?
|
End Stage Liver Disease | 14 | 2023 | 370 | 4.940 |
Why?
|
Hepatectomy | 24 | 2024 | 588 | 3.230 |
Why?
|
Carcinoma, Hepatocellular | 21 | 2024 | 2331 | 2.950 |
Why?
|
Donor Selection | 8 | 2021 | 240 | 2.730 |
Why?
|
Liver Neoplasms | 24 | 2024 | 4362 | 2.490 |
Why?
|
Graft Survival | 24 | 2024 | 3890 | 2.410 |
Why?
|
Tissue Donors | 20 | 2024 | 2377 | 1.970 |
Why?
|
Hospitals | 13 | 2019 | 3906 | 1.710 |
Why?
|
Hepatitis C | 6 | 2024 | 1594 | 1.330 |
Why?
|
Kidney Transplantation | 12 | 2023 | 4285 | 1.240 |
Why?
|
Living Donors | 8 | 2019 | 651 | 1.230 |
Why?
|
Direct Service Costs | 2 | 2018 | 61 | 1.140 |
Why?
|
Hospital Costs | 8 | 2017 | 959 | 1.130 |
Why?
|
Tissue and Organ Procurement | 15 | 2024 | 983 | 1.120 |
Why?
|
Waiting Lists | 8 | 2024 | 778 | 1.090 |
Why?
|
Kidney Failure, Chronic | 7 | 2023 | 2489 | 1.050 |
Why?
|
Hepatitis B | 2 | 2021 | 707 | 1.010 |
Why?
|
Patient Readmission | 13 | 2019 | 3308 | 0.990 |
Why?
|
Colectomy | 8 | 2017 | 700 | 0.940 |
Why?
|
Cholecystectomy, Laparoscopic | 4 | 2017 | 236 | 0.940 |
Why?
|
Hospital Mortality | 22 | 2019 | 5371 | 0.900 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2023 | 34 | 0.870 |
Why?
|
Pancreatectomy | 10 | 2019 | 824 | 0.800 |
Why?
|
Pancreatic Neoplasms | 12 | 2023 | 5442 | 0.800 |
Why?
|
Retrospective Studies | 84 | 2024 | 81834 | 0.790 |
Why?
|
Hepatitis C Antibodies | 2 | 2019 | 151 | 0.780 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2024 | 9425 | 0.760 |
Why?
|
Health Resources | 4 | 2016 | 950 | 0.750 |
Why?
|
Obesity, Morbid | 6 | 2019 | 1309 | 0.750 |
Why?
|
Middle Aged | 105 | 2024 | 223418 | 0.720 |
Why?
|
United States | 66 | 2024 | 73121 | 0.700 |
Why?
|
Length of Stay | 25 | 2019 | 6521 | 0.700 |
Why?
|
Aged | 89 | 2024 | 171520 | 0.690 |
Why?
|
Abdominal Injuries | 1 | 2023 | 365 | 0.690 |
Why?
|
Digestive System Surgical Procedures | 3 | 2017 | 584 | 0.680 |
Why?
|
Survival Rate | 31 | 2024 | 12875 | 0.670 |
Why?
|
Postoperative Complications | 27 | 2023 | 15880 | 0.670 |
Why?
|
Registries | 17 | 2019 | 8373 | 0.670 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2023 | 389 | 0.660 |
Why?
|
Treatment Outcome | 52 | 2024 | 65409 | 0.660 |
Why?
|
Laparoscopy | 7 | 2019 | 2056 | 0.630 |
Why?
|
Hepacivirus | 4 | 2024 | 1342 | 0.610 |
Why?
|
Adult | 78 | 2024 | 223542 | 0.600 |
Why?
|
Time Factors | 29 | 2024 | 40271 | 0.600 |
Why?
|
Male | 117 | 2024 | 364781 | 0.590 |
Why?
|
Female | 116 | 2024 | 396943 | 0.550 |
Why?
|
Databases, Factual | 20 | 2024 | 8081 | 0.550 |
Why?
|
Remote Consultation | 1 | 2019 | 242 | 0.550 |
Why?
|
Hepatitis B virus | 1 | 2020 | 530 | 0.540 |
Why?
|
After-Hours Care | 1 | 2017 | 102 | 0.540 |
Why?
|
General Surgery | 4 | 2019 | 1714 | 0.540 |
Why?
|
Humans | 152 | 2024 | 768451 | 0.540 |
Why?
|
Surgical Procedures, Operative | 2 | 2018 | 1937 | 0.530 |
Why?
|
Hepatitis C, Chronic | 2 | 2021 | 1031 | 0.520 |
Why?
|
Pancreas Transplantation | 1 | 2017 | 198 | 0.520 |
Why?
|
Gastrectomy | 7 | 2020 | 696 | 0.500 |
Why?
|
Biliary Tract Surgical Procedures | 4 | 2019 | 50 | 0.490 |
Why?
|
Esophageal and Gastric Varices | 2 | 2014 | 212 | 0.480 |
Why?
|
Vulnerable Populations | 2 | 2019 | 717 | 0.480 |
Why?
|
Follow-Up Studies | 23 | 2024 | 39430 | 0.470 |
Why?
|
Kaplan-Meier Estimate | 15 | 2022 | 6537 | 0.470 |
Why?
|
Postoperative Care | 3 | 2017 | 1481 | 0.450 |
Why?
|
Death | 3 | 2022 | 683 | 0.440 |
Why?
|
Liver | 5 | 2020 | 7575 | 0.440 |
Why?
|
Risk Factors | 44 | 2024 | 74915 | 0.440 |
Why?
|
Graft Rejection | 5 | 2022 | 4505 | 0.420 |
Why?
|
Neoadjuvant Therapy | 4 | 2020 | 2896 | 0.420 |
Why?
|
Medicaid | 3 | 2022 | 2843 | 0.410 |
Why?
|
Healthcare Disparities | 5 | 2024 | 3412 | 0.410 |
Why?
|
Telemedicine | 2 | 2021 | 3104 | 0.410 |
Why?
|
Ohio | 3 | 2018 | 328 | 0.410 |
Why?
|
Logistic Models | 19 | 2018 | 13324 | 0.410 |
Why?
|
Esophagectomy | 5 | 2023 | 482 | 0.390 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1795 | 0.380 |
Why?
|
Chi-Square Distribution | 10 | 2016 | 3438 | 0.380 |
Why?
|
Brain Death | 1 | 2015 | 360 | 0.380 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1435 | 0.380 |
Why?
|
Abdomen | 3 | 2023 | 1136 | 0.370 |
Why?
|
Young Adult | 24 | 2019 | 60045 | 0.370 |
Why?
|
Liver Failure | 2 | 2019 | 252 | 0.370 |
Why?
|
Cholangiocarcinoma | 3 | 2023 | 563 | 0.360 |
Why?
|
Bile Duct Neoplasms | 3 | 2023 | 617 | 0.360 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15965 | 0.360 |
Why?
|
Quality Indicators, Health Care | 2 | 2012 | 1813 | 0.350 |
Why?
|
Multivariate Analysis | 16 | 2018 | 12096 | 0.350 |
Why?
|
Cholecystostomy | 1 | 2010 | 49 | 0.350 |
Why?
|
Esophageal Neoplasms | 4 | 2023 | 1676 | 0.350 |
Why?
|
Intubation | 1 | 2010 | 140 | 0.340 |
Why?
|
Health Status Disparities | 3 | 2017 | 1876 | 0.330 |
Why?
|
Cholecystitis, Acute | 1 | 2010 | 76 | 0.330 |
Why?
|
Neoplasm Staging | 17 | 2024 | 11249 | 0.330 |
Why?
|
Decompression, Surgical | 1 | 2014 | 612 | 0.330 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 114 | 0.330 |
Why?
|
Social Class | 3 | 2019 | 2000 | 0.330 |
Why?
|
Adolescent | 23 | 2019 | 89168 | 0.320 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2014 | 1126 | 0.320 |
Why?
|
Cholecystectomy | 3 | 2017 | 409 | 0.320 |
Why?
|
Transplants | 1 | 2011 | 208 | 0.320 |
Why?
|
Patient Participation | 1 | 2017 | 1450 | 0.310 |
Why?
|
Spleen | 1 | 2014 | 2298 | 0.310 |
Why?
|
Nephrectomy | 2 | 2010 | 949 | 0.300 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1677 | 0.300 |
Why?
|
Fatty Liver | 1 | 2014 | 807 | 0.300 |
Why?
|
Social Support | 1 | 2017 | 2195 | 0.290 |
Why?
|
Anastomotic Leak | 3 | 2022 | 171 | 0.290 |
Why?
|
Emergencies | 3 | 2018 | 1222 | 0.280 |
Why?
|
Diverticulitis | 1 | 2009 | 187 | 0.270 |
Why?
|
Odds Ratio | 11 | 2017 | 9687 | 0.270 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2785 | 0.270 |
Why?
|
Blood Transfusion | 3 | 2020 | 1308 | 0.260 |
Why?
|
Risk Assessment | 18 | 2019 | 24311 | 0.260 |
Why?
|
Health Services Accessibility | 4 | 2018 | 5510 | 0.250 |
Why?
|
Antiviral Agents | 4 | 2024 | 3063 | 0.240 |
Why?
|
Medicare | 2 | 2023 | 6881 | 0.240 |
Why?
|
Urinary Fistula | 1 | 2004 | 44 | 0.240 |
Why?
|
Rectal Neoplasms | 3 | 2020 | 1179 | 0.230 |
Why?
|
Rectal Fistula | 1 | 2004 | 76 | 0.220 |
Why?
|
Survival Analysis | 5 | 2017 | 10125 | 0.220 |
Why?
|
Varicose Veins | 1 | 2005 | 157 | 0.220 |
Why?
|
Incidence | 12 | 2019 | 21552 | 0.220 |
Why?
|
Patient Discharge | 6 | 2017 | 3471 | 0.220 |
Why?
|
Anastomosis, Surgical | 3 | 2020 | 993 | 0.220 |
Why?
|
Policy | 3 | 2023 | 515 | 0.220 |
Why?
|
Specialties, Surgical | 1 | 2008 | 393 | 0.220 |
Why?
|
Pancreatitis | 2 | 2012 | 1087 | 0.220 |
Why?
|
Jejunostomy | 1 | 2023 | 61 | 0.220 |
Why?
|
Aged, 80 and over | 21 | 2024 | 59680 | 0.220 |
Why?
|
Fibrosis | 1 | 2010 | 2076 | 0.220 |
Why?
|
SEER Program | 8 | 2024 | 1476 | 0.210 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2017 | 1794 | 0.210 |
Why?
|
Pancreaticoduodenectomy | 3 | 2023 | 516 | 0.210 |
Why?
|
Adenocarcinoma | 6 | 2020 | 6400 | 0.210 |
Why?
|
Prognosis | 19 | 2024 | 30028 | 0.200 |
Why?
|
Cohort Studies | 14 | 2022 | 41797 | 0.200 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2020 | 3550 | 0.200 |
Why?
|
Quality of Health Care | 1 | 2017 | 4340 | 0.200 |
Why?
|
Abdominal Muscles | 1 | 2023 | 172 | 0.200 |
Why?
|
Propensity Score | 5 | 2019 | 1971 | 0.200 |
Why?
|
Vena Cava, Inferior | 2 | 2020 | 463 | 0.200 |
Why?
|
Patient Admission | 1 | 2009 | 1370 | 0.200 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2021 | 25 | 0.190 |
Why?
|
Medically Uninsured | 2 | 2017 | 841 | 0.190 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3837 | 0.190 |
Why?
|
Cause of Death | 3 | 2021 | 3727 | 0.190 |
Why?
|
Costs and Cost Analysis | 2 | 2018 | 1670 | 0.180 |
Why?
|
Laparotomy | 1 | 2023 | 459 | 0.180 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2179 | 0.180 |
Why?
|
Proportional Hazards Models | 8 | 2016 | 12561 | 0.180 |
Why?
|
Hyperparathyroidism | 1 | 2022 | 339 | 0.180 |
Why?
|
Physicians | 2 | 2009 | 4615 | 0.180 |
Why?
|
Disease-Free Survival | 6 | 2008 | 6856 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3440 | 0.170 |
Why?
|
Uronic Acids | 1 | 2019 | 17 | 0.170 |
Why?
|
Liver Diseases | 1 | 2008 | 1307 | 0.170 |
Why?
|
Reoperation | 4 | 2016 | 4342 | 0.160 |
Why?
|
Pancreas | 2 | 2019 | 1703 | 0.160 |
Why?
|
Trust | 1 | 2024 | 532 | 0.160 |
Why?
|
Matched-Pair Analysis | 2 | 2021 | 286 | 0.160 |
Why?
|
Intestine, Small | 1 | 2005 | 1218 | 0.160 |
Why?
|
Warm Ischemia | 1 | 2019 | 59 | 0.160 |
Why?
|
Hospitalization | 3 | 2018 | 10845 | 0.160 |
Why?
|
Neuroendocrine Tumors | 1 | 2005 | 649 | 0.160 |
Why?
|
Cold Ischemia | 1 | 2019 | 73 | 0.160 |
Why?
|
Pneumonectomy | 1 | 2006 | 1159 | 0.160 |
Why?
|
Minority Groups | 2 | 2024 | 1215 | 0.150 |
Why?
|
Health Care Costs | 3 | 2024 | 3265 | 0.150 |
Why?
|
Organ Transplantation | 1 | 2008 | 1177 | 0.150 |
Why?
|
Kidney Diseases | 2 | 2021 | 2102 | 0.150 |
Why?
|
Postoperative Period | 3 | 2019 | 1833 | 0.150 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6978 | 0.150 |
Why?
|
Alcohol Drinking | 1 | 2010 | 4052 | 0.140 |
Why?
|
Lung | 2 | 2021 | 10090 | 0.140 |
Why?
|
Pancreatic Fistula | 1 | 2018 | 149 | 0.140 |
Why?
|
Water-Electrolyte Balance | 1 | 2018 | 326 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2004 | 1205 | 0.140 |
Why?
|
Patient Selection | 5 | 2016 | 4266 | 0.140 |
Why?
|
Cathartics | 1 | 2017 | 129 | 0.140 |
Why?
|
Brachytherapy | 1 | 2004 | 1227 | 0.140 |
Why?
|
Markov Chains | 1 | 2020 | 977 | 0.140 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 129 | 0.130 |
Why?
|
Tissue Adhesions | 1 | 2017 | 223 | 0.130 |
Why?
|
Clinical Competence | 3 | 2019 | 4841 | 0.130 |
Why?
|
Peptic Ulcer | 1 | 2017 | 222 | 0.130 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5532 | 0.130 |
Why?
|
Stomach Neoplasms | 2 | 2020 | 1484 | 0.130 |
Why?
|
Patient Satisfaction | 2 | 2019 | 3484 | 0.130 |
Why?
|
Confidence Intervals | 3 | 2016 | 2932 | 0.130 |
Why?
|
Data Collection | 2 | 2015 | 3329 | 0.130 |
Why?
|
Preoperative Period | 1 | 2018 | 564 | 0.120 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13589 | 0.120 |
Why?
|
Faculty, Medical | 1 | 2024 | 1218 | 0.120 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2015 | 50 | 0.120 |
Why?
|
Pilot Projects | 2 | 2019 | 8730 | 0.120 |
Why?
|
Prospective Studies | 7 | 2024 | 54914 | 0.120 |
Why?
|
Carcinoma | 1 | 2006 | 2341 | 0.110 |
Why?
|
Fluid Therapy | 1 | 2018 | 585 | 0.110 |
Why?
|
Age Factors | 7 | 2016 | 18478 | 0.110 |
Why?
|
Poisson Distribution | 1 | 2015 | 509 | 0.110 |
Why?
|
Appendectomy | 1 | 2017 | 442 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 712 | 0.110 |
Why?
|
Preoperative Care | 3 | 2017 | 2257 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2015 | 191 | 0.110 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2015 | 174 | 0.110 |
Why?
|
Early Detection of Cancer | 2 | 2020 | 3230 | 0.110 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1734 | 0.110 |
Why?
|
Colonic Diseases | 1 | 2015 | 203 | 0.110 |
Why?
|
Probability | 2 | 2009 | 2483 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2019 | 1479 | 0.110 |
Why?
|
Referral and Consultation | 2 | 2021 | 3629 | 0.110 |
Why?
|
Geography | 1 | 2015 | 654 | 0.110 |
Why?
|
Risk Adjustment | 1 | 2016 | 603 | 0.100 |
Why?
|
Resource Allocation | 1 | 2015 | 353 | 0.100 |
Why?
|
Proctocolectomy, Restorative | 1 | 2014 | 191 | 0.100 |
Why?
|
Cholangiography | 1 | 2013 | 182 | 0.100 |
Why?
|
Comorbidity | 6 | 2010 | 10601 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 640 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1014 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1076 | 0.100 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 317 | 0.100 |
Why?
|
Biliary Tract Diseases | 1 | 2013 | 159 | 0.100 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1544 | 0.100 |
Why?
|
Health Policy | 1 | 2024 | 2699 | 0.100 |
Why?
|
Bile Ducts | 1 | 2013 | 288 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2023 | 304 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2009 | 2437 | 0.090 |
Why?
|
Venous Thrombosis | 2 | 2014 | 1318 | 0.090 |
Why?
|
Models, Economic | 1 | 2015 | 717 | 0.090 |
Why?
|
Hospital Departments | 1 | 2011 | 135 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2024 | 3267 | 0.090 |
Why?
|
Perioperative Care | 1 | 2018 | 1046 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12242 | 0.090 |
Why?
|
Socioeconomic Factors | 3 | 2015 | 7863 | 0.090 |
Why?
|
Neuroectodermal Tumors | 1 | 2010 | 23 | 0.090 |
Why?
|
Quality of Life | 3 | 2020 | 13497 | 0.090 |
Why?
|
Rectum | 1 | 2015 | 902 | 0.090 |
Why?
|
Decision Making | 1 | 2024 | 3961 | 0.090 |
Why?
|
Duodenum | 1 | 2013 | 495 | 0.090 |
Why?
|
Hepatorenal Syndrome | 1 | 2010 | 76 | 0.090 |
Why?
|
Liver Function Tests | 1 | 2011 | 527 | 0.080 |
Why?
|
Hepatic Encephalopathy | 1 | 2010 | 144 | 0.080 |
Why?
|
Drainage | 1 | 2015 | 1179 | 0.080 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2013 | 362 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 1007 | 0.080 |
Why?
|
Ventricular Function, Right | 1 | 2013 | 629 | 0.080 |
Why?
|
Ontario | 2 | 2011 | 403 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2019 | 1103 | 0.080 |
Why?
|
Ascites | 1 | 2010 | 339 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3637 | 0.080 |
Why?
|
Hospital Charges | 1 | 2010 | 351 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6091 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2011 | 541 | 0.080 |
Why?
|
New York | 1 | 2010 | 882 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2017 | 1802 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2010 | 187 | 0.070 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2013 | 645 | 0.070 |
Why?
|
Body Mass Index | 2 | 2016 | 13030 | 0.070 |
Why?
|
Splenectomy | 1 | 2009 | 392 | 0.070 |
Why?
|
Digestive System Diseases | 1 | 2009 | 152 | 0.070 |
Why?
|
Motivation | 1 | 2017 | 2034 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2011 | 22293 | 0.070 |
Why?
|
Accreditation | 2 | 2022 | 478 | 0.070 |
Why?
|
Health Status | 2 | 2018 | 4096 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1755 | 0.070 |
Why?
|
Emergency Treatment | 1 | 2011 | 496 | 0.070 |
Why?
|
Adrenalectomy | 1 | 2009 | 348 | 0.070 |
Why?
|
Ventilator Weaning | 1 | 2008 | 170 | 0.070 |
Why?
|
Gastroenterology | 1 | 2013 | 588 | 0.070 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2010 | 335 | 0.070 |
Why?
|
Qualitative Research | 1 | 2017 | 3115 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2239 | 0.070 |
Why?
|
Sternum | 1 | 2007 | 177 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2950 | 0.060 |
Why?
|
Insurance, Health | 1 | 2018 | 2513 | 0.060 |
Why?
|
Morbidity | 1 | 2011 | 1760 | 0.060 |
Why?
|
Vascular Neoplasms | 1 | 2007 | 167 | 0.060 |
Why?
|
Diaphragm | 1 | 2007 | 360 | 0.060 |
Why?
|
Mesenteric Veins | 1 | 2005 | 87 | 0.060 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2009 | 526 | 0.060 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2005 | 121 | 0.060 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2005 | 93 | 0.060 |
Why?
|
Ampulla of Vater | 1 | 2005 | 150 | 0.060 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 643 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2544 | 0.060 |
Why?
|
Kidney | 2 | 2020 | 7064 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2775 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2018 | 3291 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 792 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4834 | 0.050 |
Why?
|
Intubation, Gastrointestinal | 1 | 2023 | 166 | 0.050 |
Why?
|
Hypotension | 1 | 2008 | 888 | 0.050 |
Why?
|
Microcirculation | 1 | 2007 | 1282 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 2010 | 0.050 |
Why?
|
Regression Analysis | 1 | 2011 | 6353 | 0.050 |
Why?
|
Health Services Research | 1 | 2009 | 1815 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11206 | 0.050 |
Why?
|
Cultural Competency | 1 | 2024 | 303 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4713 | 0.050 |
Why?
|
Efficiency | 1 | 2024 | 477 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8559 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2518 | 0.040 |
Why?
|
Fluorenes | 1 | 2021 | 160 | 0.040 |
Why?
|
Carbamates | 1 | 2021 | 192 | 0.040 |
Why?
|
Parathyroidectomy | 1 | 2022 | 244 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2444 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6242 | 0.040 |
Why?
|
Pyrrolidines | 1 | 2021 | 341 | 0.040 |
Why?
|
Quinoxalines | 1 | 2021 | 297 | 0.040 |
Why?
|
Mass Screening | 1 | 2015 | 5455 | 0.040 |
Why?
|
Sarcoma | 1 | 2010 | 1806 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7246 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5952 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2012 | 3805 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2022 | 726 | 0.040 |
Why?
|
Hemorrhage | 1 | 2010 | 3458 | 0.040 |
Why?
|
Weight Loss | 2 | 2019 | 2710 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15880 | 0.040 |
Why?
|
Enteral Nutrition | 1 | 2023 | 804 | 0.040 |
Why?
|
Surgical Stapling | 1 | 2018 | 100 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 469 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20762 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 959 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 515 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 864 | 0.030 |
Why?
|
Sex Factors | 2 | 2024 | 10647 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1276 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2022 | 848 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1804 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2079 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6657 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13708 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1134 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4861 | 0.030 |
Why?
|
Workload | 1 | 2019 | 852 | 0.030 |
Why?
|
Patient Care Team | 1 | 2024 | 2526 | 0.030 |
Why?
|
Linear Models | 2 | 2013 | 5880 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2019 | 1277 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2015 | 249 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26351 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 835 | 0.030 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.020 |
Why?
|
Smoking | 2 | 2021 | 9099 | 0.020 |
Why?
|
Sulfonamides | 1 | 2021 | 1988 | 0.020 |
Why?
|
Disease Progression | 1 | 2007 | 13655 | 0.020 |
Why?
|
Oxygen | 1 | 2021 | 4269 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3910 | 0.020 |
Why?
|
Viral Load | 1 | 2019 | 3399 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4041 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 475 | 0.020 |
Why?
|
Indocyanine Green | 1 | 2011 | 239 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2881 | 0.020 |
Why?
|
Algorithms | 2 | 2009 | 14158 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2013 | 772 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5793 | 0.020 |
Why?
|
Coloring Agents | 1 | 2011 | 564 | 0.020 |
Why?
|
Infant | 1 | 2010 | 36497 | 0.020 |
Why?
|
Cholelithiasis | 1 | 2009 | 408 | 0.020 |
Why?
|
Child, Preschool | 1 | 2010 | 42623 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4796 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2411 | 0.020 |
Why?
|
Specialization | 1 | 2009 | 782 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36840 | 0.010 |
Why?
|
Child | 1 | 2010 | 80863 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20231 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3624 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5995 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1359 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3858 | 0.010 |
Why?
|
Treatment Failure | 1 | 2005 | 2656 | 0.010 |
Why?
|
Models, Statistical | 1 | 2012 | 5103 | 0.010 |
Why?
|
Medical Oncology | 1 | 2009 | 2347 | 0.010 |
Why?
|
Radiography | 1 | 2008 | 6995 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11843 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8538 | 0.010 |
Why?
|